PhosLo
PhosLo (calcium acetate) is a new phosphate binder available for the prevention...
News
RSSValdoxan
Servier has launched Valdoxan (agomelatine) for the treatment of major depressive episodes in adults.
New Drugs
Valdoxan
Servier has launched Valdoxan (agomelatine) for the treatment of major depressive episodes...
Qlaira
Bayer has launched Qlaira, the first combined oral contraceptive to use estradiol...
Firmagon
Degarelix is the first gonadotrophin releasing-hormone (GnRH) antagonist licensed for use in...
Extavia
A new interferon beta-1b available for the management of multiple sclerosis.
Licence Changes & Product Updates
BuTrans in moderate chronic pain
BuTrans ( buprenorphine ) patches are now indicated in the management of...
Diovan for heart failure
The angiotensin II antagonist Diovan (valsartan) is now licensed for the treatment...
Glivec licence extension
The licence for Glivec (imatinib) has been extended to include its use...
Deleted products
The following products were discontinued from the UK market during 2009. The list...
Glucophage powder
Merck Serono has launched a new powder formulation of Glucophage (metformin) for...
Guidelines & Clinical Updates
Interaction between clopidogrel and PPIs
The EU Committee for Medicinal Products for Human Use (CHMP) has stated...
NICE guidance on diarrhoea and vomiting in children
NICE has issued guidance on the diagnosis, assessment and management of acute...
NICE advises on sunitinib in renal cell carcinoma
NICE has issued criteria that should be met before the use of...
Changes to NICE influenza treatment guidance
NICE has updated its guidance on the treatment of influenza following a...
NICE schizophrenia guidance updated
NICE has issued an update to its schizophrenia guidance, replacing previous guidance...
MIMs Drug Search
Possible searches include drugs (by brand, generic ingredient or drug class), diseases and more.
Deleted products
Cumulative list of products discontinued from the UK market
in 2009.
